Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock Has Consensus Target Price of $14.06 According to Analysts

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have earned an average rating of “Moderate Buy” from the twelve research firms that are covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $14.06.

A number of equities research analysts have weighed in on AVAH shares. Royal Bank Of Canada lifted their price objective on Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a report on Monday, August 24th. Truist Financial increased their target price on Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a report on Monday, August 24th. Raymond James Financial raised their target price on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research report on Friday, August 14th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Finally, BMO Capital Markets upped their price target on Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a research report on Friday, August 14th.

Aveanna Healthcare Price Performance

Shares of NASDAQ:AVAH opened at $12.38 on Friday. The company has a market cap of $2.70 billion, a price-to-earnings ratio of 10.07, a PEG ratio of 0.81 and a beta of 1.97. The business has a 50 day moving average price of $11.91 and a 200 day moving average price of $8.94. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. Aveanna Healthcare has a twelve month low of $5.93 and a twelve month high of $14.71.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The business had revenue of $670.48 million during the quarter, compared to analyst estimates of $638.61 million. Research analysts predict that Aveanna Healthcare will post 0.77 earnings per share for the current year.

Insider Buying and Selling

In other news, major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of Aveanna Healthcare stock in a transaction on Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the sale, the insider directly owned 12,315,892 shares of the company’s stock, valued at approximately $141,632,758. This trade represents a 15.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jeff Shaner sold 90,000 shares of Aveanna Healthcare stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $1,035,000.00. Following the completion of the sale, the chief executive officer owned 2,561,972 shares of the company’s stock, valued at approximately $29,462,678. The trade was a 3.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 56,985,116 shares of company stock valued at $625,946,402 in the last 90 days. 5.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Aveanna Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. acquired a new stake in Aveanna Healthcare during the 2nd quarter worth $63,504,000. Braidwell LP increased its holdings in shares of Aveanna Healthcare by 39.1% in the second quarter. Braidwell LP now owns 3,065,106 shares of the company’s stock worth $26,268,000 after acquiring an additional 861,600 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Aveanna Healthcare by 49.5% in the first quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock worth $8,593,000 after acquiring an additional 441,707 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Aveanna Healthcare during the second quarter worth about $7,881,000. Finally, Assenagon Asset Management S.A. lifted its holdings in shares of Aveanna Healthcare by 16.4% during the 1st quarter. Assenagon Asset Management S.A. now owns 951,594 shares of the company’s stock valued at $6,128,000 after purchasing an additional 134,043 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Corporation is a provider of home-based healthcare services for children, adults and families in the United States. The company’s services are designed to help patients receive medical and supportive care in their homes and communities, including individuals with complex, chronic or medically fragile conditions.

Aveanna’s principal services include private-duty nursing, home health, hospice and personal care. It also provides pediatric therapy and related clinical services, including physical, occupational and speech therapy.